Research Goals
Our goal is to understand the molecular mechanisms of neuronal development and regeneration, and to utilize gained knowledge in developing translational approaches for repairing injured central nervous system (CNS) circuits.
An image of immature retinal ganglion cell neuron from Dr. Trakhtenberg's research, adapted for a cover page of the International Review of Neurobiology volume on Axon Growth and Regeneration (Goldberg & Trakhtenberg, Eds, 2012, Vol 106: Academic Press).
NEWS
July, 2019
Dr. Trakhtenberg received UConn Health's Faculty Spotlight recognition for “Research Excellence”, which includes being awarded an NIH grant for his novel research approach to restoring vision loss.
June, 2019
Dr. Trakhtenberg received Spotlight recognition at the BrightFocus Foundation, which funds his research on investigating novel gene therapy approach towards developing neuroregenerative treatments for restoring vision after certain types of glaucoma and other types of optic neuropathies.
June, 2019
Bruce Rheaume, MD/PhD Candidate, won Biomedical Science Program Mentorship Award for outstanding mentorship by a student in the biomedical science program.
May, 2019
Dr. Trakhtenberg was awarded a 2 million 5-year R01 grant by the National Institutes of Health's Eye Institute (NEI) to investigate how small non-coding RNAs regulate retinal ganglion cell maturation and to utilize their potential for regenerating the optic nerve axons damaged in optic neuropathies.
August, 2018
Our lab in collaboration with JAX published in Nature Communications molecular classification of retinal ganglion cells into subtypes, covered in the news.
June, 2018
Dr. Trakhtenberg and Dr. Wu were awarded a Research Excellence Program Grant by The Office of the Vice President for Research, UConn School of Medicine and School of Dental Medicine.
June, 2018
Our lab published in Scientific Reports that the extent of non-atrophic extra-axonal tissue damage determines the success of experimental axon regeneration targeting neuronal intrinsic mechanisms.
May, 2018
Dr. Trakhtenberg and Dr. Rouge were awarded a PITCH Seed Award Grant by the PITCH, featured in UConnToday news.
March, 2018
Dr. Trakhtenberg has received Artificial Intelligence Molecular Screen (AIMS) Award, Atomwise Inc (San Francisco, CA) .
November, 2017
An MD-PhD student, Bruce Rheaume, presented a poster from the lab, "Axotomized adult retinal ganglion cells stimulated by extrinsic cues in a permissive environment survive and regenerate axons", at the international annual meeting of the Society for Neuroscience (SFN) in Washington, DC.
September, 2017
Dr. Trakhtenberg’s awards and his lab were featured in UConnToday news.
June, 2017
Dr. Trakhtenberg (lead PI) and Dr. Crocker (co-PI) were awarded a seed grant by the Connecticut Institute for the Brain and Cognitive Sciences (IBaCS). The grant will fund a research project to test a novel hypothesis regarding why axonal connections, through which neurons in the brain communicate with each other over long distances, do not regenerate after traumatic or stroke injury.
April, 2017
Dr. Trakhtenberg was awarded a research grant by the BrightFocus Foundation under the National Glaucoma Research Program. The grant will fund a research project aimed at investigating novel gene therapy approach towards developing neuroregenerative treatments for restoring vision after angle-closure glaucoma and other types of optic neuropathies, which lead to complete or partial blindness.
March, 2017
Dr. Trakhtenberg was selected by the New York Academy of Sciences and the Japan Agency for Medical Research and Development to participate at the Interstellar Initiative for “the world's most promising Early Career Investigators”, where along with a collaborator, Dr. Kumiko Hayashi, they won First Place Award for a research solution proposal in the field of neuroscience.
